This protocol serves two purposes: To collect and store relevant biological specimens for repository biobanking to…
Category: Studies
Efficacy and liver fibrosis improvement in compensated cirrhotic patients with chronic HCV genotypes 1 and 6 infection with and without HIV co-infection receiving the combination regimen of Grazoprevir and Elbasvir
This study will evaluate the safety and efficacy of combination treatment with grazoprevir + elbasvir for…
Cross-sectional study examining the prevalence rate and determinants of frailty in the HIV positive and negative Thai populations
This is a cross-sectional study examining the prevalence rate and determinants of frailty in the HIV…
Liver disease progression in HIV/HBV co-infection SOFIA: cross-sectional cohort
This is a cross-sectional, international multi-site cohort study to investigate the relationship between changes on liver…
An international observational study to characterize adults who are hospitalized with complications of influenza A – pandemic H1N1 (H1N1v)
The purpose of this observational study is to describe the characteristics and outcomes over a 60-day…
Maintenance of switching from Protease Inhibitor/Ritonavir to generic single tablet regimen of Tenofovir Alafenamide/Emtricitibine/Dolutegravir in virologically suppressed HIV-infected adults
The fundamental principle of regimen switching is to maintain viral suppression without jeopardizing future treatment options.
A phase 3b, randomized, open-label study of the safety and efficacy of Dolutegravir/Abacavir/Lamivudine once daily compared to Atazanavir and Ritonavir plus Tenofovir/Emtricitabine once daily in HIV-1 infected antiretroviral therapy naïve women
This study is designed to demonstrate the non-inferior antiviral activity of DTG/ABC/3TC fixed dose combination (FDC)…
Treatment outcome of children with HIV infection treated with highly active antiretroviral therapy (HAART)
This is a long-term follow-up study of safety and efficacy of antiretroviral therapy for HIV positive…
A phase 3 multicenter, double-blind, randomized, active comparator-controlled clinical trial to evaluate the safety and efficacy of MK-1439A once-daily versus ATRIPLA once-daily in treatment-naïve HIV-1 infected subjects
This study will compare the antiretroviral activity of MK-1439A, a single-tablet, once-daily (q.d.) fixed-dose combination (FDC)…
Management Using the Latest Technologies In resource-limited settings to Optimize Combination Therapy After Viral Failure (MULTI-OCTAVE)
This is a randomized, open labelled, multicentered international study that will assess the efficacy, safety and…
A pilot study of the pharmacokinetics and safety of Rifabutin 150 mg once daily versus Rifabutin 150 mg thrice weekly with Lopinavir/Ritonavir based HAART in HIV/TB co-infected patients
This is a pilot, randomized, open-label, 2-arm per group, parallel, phase II study that will describe…
A phase 2 intensification study of BIT225, a HIV-1 Vpu inhibitor, in HIV-1 infected individual initiating combination antiretroviral therapy (cART)
This is a phase 2, intensification study of BIT225, a HIV-1 Vpu inhibitor, in HIV-1 Infected…
Collection of key tuberculosis (TB) variables in antiretroviral therapy (ART) programs within the international epidemiologic databases to evaluate AIDS (IeDEA) consortium: Diagnostics, treatment and risk factors for incident TB
The overall goal is to collect, retrospectively and prospectively, key TB variables in ART programs within…
Open label phase 2/3, multicenter, trial to assess the efficacy, safety, tolerance, and pharmacokinetics of sofosbuvir plus ravidasvir in HCV (+/- HIV) chronically infected adults with no or compensated cirrhosis in Thailand and Malaysia
This is an open label phase II/III, multicenter, trial to assess the efficacy, safety, tolerance, and…
Incidence of tuberculosis in difference of CD4 cell count among HIV infected patients receiving antiretroviral treatment and innovative of self assessment tuberculin skin test for latent TB screening in resource limited settings
This study was divided into two parts. The first part will retrospectively assess the incidence of…
